Skip to content Skip to sidebar Skip to footer
Star Entertainment
Star Entertainment (ASX:SGR) Drops 16% Despite First EBITDA Profit in Quarters: Buy, Sell, or Wait?
Star Entertainment turns EBITDA positive but survival risks remain Star Entertainment (ASX: SGR) plunged 16 per cent to A$0.14 on Friday despite reporting its first positive underlying EBITDA in several quarters. The casino operator posted A$301 million in revenue for the December quarter, up 6 per cent from the previous period. More importantly, it delivered…
Apollo Minerals
Apollo Minerals Raises A$6.5m Following 200% Surge- Buy, Hold, or Take Profits?
Apollo Minerals secures permit win and $6.5m raise as tungsten tightens Apollo Minerals (ASX: AON) surged more than 200 per cent this week after France's highest court reinstated its exploration permit at the Couflens tungsten-gold project. The company followed up by raising A$6.5 million to accelerate drilling and feasibility work at the historic Salau mine,…
Liontown
Liontown (ASX:LTR) Delivers 91% Revenue Surge in Q2 After Historic Underground Milestone- Time to Buy or Take Profits?
Liontown Hits Cashflow Neutral After Going Fully Underground Liontown (ASX: LTR) just hit a major turning point. The company delivered its December quarter results this week, and for the first time since production began, Kathleen Valley is paying its own way. Revenue jumped 91% to A$130 million, while unit operating costs fell 17% to A$910…
fortuna metals
Whitehaven Coal (ASX:WHC) Smashes Q2 Expectations With 21% Production Surge- Is It Time to Buy?
Whitehaven Coal Rallies After Q2 Output Surge Whitehaven Coal (ASX: WHC) gained nearly 3 per cent on Thursday after delivering a Q2 FY26 production report that beat market expectations. Managed run-of-mine production reached 11 million tonnes, up 21 per cent from the September quarter, driven by stronger output from both Queensland and New South Wales…
BrainChip
BrainChip (ASX:BRN) Falls 6% Despite Defence Deals and AKD1500 Production Ramp- Is This a Buying Opportunity?
BrainChip Slips Despite Defence Orders and AKD1500 Ramp BrainChip Holdings (ASX: BRN) dropped around 6% on Thursday despite releasing what appears to be its strongest quarterly update in years. The neuromorphic AI chip maker reported improved cash flows, a strengthened balance sheet, and meaningful progress on defence contracts, yet the market pushed shares toward 52-week…
Telix Pharmaceuticals
Is Telix Pharmaceuticals (ASX:TLX) a Buy After Crashing 63%? Here’s What Investors Should Know
Telix Pharmaceuticals Shares Slide After Regulatory Setbacks Telix Pharmaceuticals (ASX: TLX) has had a brutal twelve months. Shares have fallen around 63% from their February 2025 all-time high of A$31.97 to current levels near A$11.86. What makes this selloff puzzling is that the company achieved its preliminary FY 2025 revenue guidance of A$1.2 billion (US$804…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here